Active Ingredient History

NOW
  • Now
Ipilimumab, sold under the brand name Yervoy, is a monoclonal antibody medication that works to activate the immune system by targeting CTLA-4, a protein receptor that downregulates the immune system.   Wikipedia

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: No
  • Black Box: Yes
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$564.6250 - $735.9180

Australia

$4361.7758 - $17447.1186
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

ipilimumab | mdx010 | mdx 010 | mdx-010 | mdx-101 | mdx-ctla4 | mdx-ctla-4 | moab-ctla-4 | yervoy

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue